The following information was obtained through the clinical study (b)(6): it was reported the physician implanted a gore® cardioform septal occluder on (b)(6) 2020.On (b)(6) 2020, the patient was noted to have a paroxysmal supraventricular tachycardia (psvt).The study site notes that treatment was provided by the health care professional but does not specify what.On (b)(6) 2020, echocardiography performed and beta blocker medication started along with holter monitor.
|
It was reported the physician implanted a gore® cardioform septal occluder on (b)(6), 2020.On (b)(6), 2020, the patient was noted to have a paroxysmal supraventricular tachycardia (psvt).The study site notes that treatment was provided by the health care professional but does not specify what.On (b)(6) 2020, echocardiography performed and beta blocker medication started along with holter monitor.In the clinical data base the patient arrhythmia was updated to atrial fibrillation (b)(6), 2020, following holter monitor.Started subject on amiodarone and apixaban.
|